Drug comparisons
Saxagliptin vs Glimepiride
Compare saxagliptin (DPP-4 inhibitor) vs glimepiride (sulfonylurea) for type 2 diabetes: efficacy, hypoglycemia risk, weight impact, and patient suitability.
No comparison dimensions are available for this page.
Clinical context
This comparison arises when choosing an oral add-on agent after metformin for type 2 diabetes, balancing potency against hypoglycemia and weight effects.
Bottom line
Saxagliptin and glimepiride are both effective, but selection hinges on individual hypoglycemia risk, weight concerns, and cardiovascular history rather than one being superior.
All medication comparisons